Principles of adoptive T cell therapy in cancer
Research output: Contribution to journal › Journal article › Research › peer-review
Adoptive cell therapy (ACT) utilizing either tumor-infiltrating lymphocyte (TIL)-derived T cells or T cells genetically engineered to express tumor recognizing receptors has emerged as a powerful and potentially curative therapy for several cancers. Many ACT-based therapies have recently entered late-phase clinical testing, with several T cell therapies already achieving regulatory approval for the treatment of patients with B cell malignancies. In this review, we briefly outline the principles of adoptively transferred T cells for the treatment of cancer.
|Journal||Seminars in Immunopathology|
|Publication status||Published - Jan 2019|
- Adoptive cell therapy, Cancer immunotherapy, Chimeric antigen receptor, T cells, Tumor-infiltrating lymphocytes